Dr. Mostafa Analoui, Ph.D. joined Cyclica’s Board of Directors in October 2016. Dr. Analoui brings to Cyclica deep expertise in the pharmaceutical industry, venture capital, and investment. Currently, he is the Executive Director of UConn Ventures at the University of Connecticut.
Prior to joining Cyclica, Dr. Analoui served as Head of Healthcare and Life Science at The Livingston Securities. He also served as the Senior Director and the Groton/New London Site Head for Global Clinical Technology of Pfizer Inc. Global Research and Development from 2001 to February 2008, where he led the platform technology mission for the clinical development and commercial division in areas including computational medicine. He is also an Adjunct Professor in Biomedical Engineering and Entrepreneurship at the University of Connecticut, Brown University, and Northeastern University.